Life ScienceCompany
Alvogen M&A Summary
Alvogen has acquired 9 companies of its own, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Alvogen’s largest acquisition to date was in 2014, when it acquired Dream Pharma for $187M. Alvogen has acquired in 3 different US states, and 4 countries. The Company’s most targeted sectors include life science (100%).
Alvogen Ownership
Who owns Alvogen?
Alvogen is owned by Athyrium Capital Management, CVC Capital Partners and Temasek Holdings. It was acquired on June 23, 2015.
Is Alvogen PE-backed?
Yes. Alvogen is owned by private equity investors Athyrium Capital Management, CVC Capital Partners and Temasek Holdings.
Was Alvogen formerly PE-backed?
Yes. Alvogen was formerly owned by 1 private investor.
Alvogen Business Overview
Where is Alvogen headquartered?
Alvogen is headquartered in Morristown, New Jersey.
How many employees does Alvogen have?
Alvogen has 2,000 employees.
What sector is Alvogen in?
Alvogen is a life science company.
When was Alvogen founded?
Alvogen was founded in 2009.
M&A Summary
-
M&A Total Activity9
- M&A Buy Activity8
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 4
- M&A Buy/Sell Connections 7
- M&A Advisors 4
Unlimited Searches
